Literature DB >> 2405849

Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation.

J Laurence1, S K Sikder, S Jhaveri, J E Salmon.   

Abstract

Potent inhibitors of protein kinases C and A, including 1-(5 isoquinolinyl sulfonyl) 2-methyl piperazine (H7), staurosporine, and 2-aminopurine, depressed phorbol ester-induced HIV-1 virion production and HIV-specific transcripts by greater than 90% in chronically infected promonocytic cells. Suppression was dose-dependent and occurred at concentration that had little effect on cell growth. These effects appeared to be specific to activation of the PKC-diacylglycerol system. They did not alter IUdr-mediated induction of HIV. In addition, PMA enhancement of an HIV-LTR driven reporter gene was not blocked by H7 in the presence or absence of exogenous tat, at concentrations capable of inhibiting upregulation of virus at the cellular level. Insight into the biochemical mechanisms of these processes is critical to understanding interactions of HIV with the immune system, and may eventually uncover new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405849     DOI: 10.1016/0006-291x(90)91952-o

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element.

Authors:  J Laurence; S K Sikder; J Kulkosky; P Miller; P O Ts'o
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Human immunodeficiency virus infection of monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement.

Authors:  J Laurence; A Saunders; E Early; J E Salmon
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

3.  Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.

Authors:  Paul A Wender; Jung-Min Kee; Jeffrey M Warrington
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

4.  Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.

Authors:  J M Fakruddin; J Laurence
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Inducible transcriptional activation of the human immunodeficiency virus long terminal repeat by protein kinase inhibitors.

Authors:  F L Brown; E Tahaoglu; G J Graham; J J Maio
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 6.  Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency.

Authors:  Guochun Jiang; Satya Dandekar
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

7.  Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.

Authors:  Francesca Graziano; Chiara Elia; Carlo Laudanna; Guido Poli; Massimo Alfano
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.